Memorial Sloan Kettering Cancer Center (MSK) and UnitedHealthcare (UHC) today announced a new, multiyear agreement that ensures continued in-network access to MSK for UHC’s commercial members. As a result, current and new UHC-insured patients can continue to receive care at MSK without interruption.

The new agreement, effective today, includes market-aligned rate adjustments consistent with those of other National Cancer Institute (NCI)-designated cancer centers in Manhattan. These adjustments will support MSK’s continued delivery of superior patient outcomes and exceptional cancer care.

“We have reached an agreement with UnitedHealthcare that protects access to MSK for thousands of patients and ensures we can continue delivering the highest standard of cancer care,” said Selwyn M. Vickers, MD, FACS, President & CEO of MSK. “This agreement recognizes the value of MSK’s specialized cancer care model and allows us to continue advancing our mission to end cancer for life.”

In a statement United Healthcare said:

"We have reached a multi-year agreement with Memorial Sloan Kettering (MSK). Our renewed relationship provides continued, uninterrupted network access to MSK for people enrolled in UnitedHealthcare and Oxford employer-sponsored commercial plans."

“We understand how difficult and deeply personal this negotiation has been for people and their families,” said Junior Harewood, UnitedHealthcare CEO, New York. “We are pleased to renew our relationship and provide continued access to MSK for the people who rely on them for quality cancer care.”